nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—CYP1A2—Carmustine—malignant glioma	0.325	1	CbGbCtD
Riluzole—Condition aggravated—Temozolomide—malignant glioma	0.0135	0.0262	CcSEcCtD
Riluzole—Pneumonia aspiration—Carmustine—malignant glioma	0.0117	0.0227	CcSEcCtD
Riluzole—Facial paralysis—Carmustine—malignant glioma	0.00802	0.0156	CcSEcCtD
Riluzole—Hemiplegia—Carmustine—malignant glioma	0.00714	0.0139	CcSEcCtD
Riluzole—Hemiplegia—Temozolomide—malignant glioma	0.0069	0.0134	CcSEcCtD
Riluzole—Hyperacusis—Temozolomide—malignant glioma	0.00662	0.0129	CcSEcCtD
Riluzole—Traumatic liver injury—Temozolomide—malignant glioma	0.00662	0.0129	CcSEcCtD
Riluzole—VIIth nerve paralysis—Carmustine—malignant glioma	0.00622	0.0121	CcSEcCtD
Riluzole—Paranoid reaction—Carmustine—malignant glioma	0.006	0.0117	CcSEcCtD
Riluzole—Personality disorder—Carmustine—malignant glioma	0.0059	0.0115	CcSEcCtD
Riluzole—Cerebral ischaemia—Temozolomide—malignant glioma	0.0051	0.00992	CcSEcCtD
Riluzole—Tongue discolouration—Temozolomide—malignant glioma	0.0051	0.00992	CcSEcCtD
Riluzole—Faecal incontinence—Carmustine—malignant glioma	0.00505	0.00983	CcSEcCtD
Riluzole—Faecal incontinence—Temozolomide—malignant glioma	0.00488	0.0095	CcSEcCtD
Riluzole—Lymphopenia—Temozolomide—malignant glioma	0.00482	0.00937	CcSEcCtD
Riluzole—Cerebral haemorrhage—Carmustine—malignant glioma	0.00461	0.00896	CcSEcCtD
Riluzole—Cerebral haemorrhage—Temozolomide—malignant glioma	0.00445	0.00866	CcSEcCtD
Riluzole—Myasthenia—Carmustine—malignant glioma	0.00406	0.00789	CcSEcCtD
Riluzole—Oral candidiasis—Carmustine—malignant glioma	0.00401	0.00781	CcSEcCtD
Riluzole—Oral candidiasis—Temozolomide—malignant glioma	0.00388	0.00755	CcSEcCtD
Riluzole—Embolism—Temozolomide—malignant glioma	0.00384	0.00747	CcSEcCtD
Riluzole—Cyst—Carmustine—malignant glioma	0.00381	0.00742	CcSEcCtD
Riluzole—Tooth disorder—Temozolomide—malignant glioma	0.0038	0.00739	CcSEcCtD
Riluzole—Hypokinesia—Carmustine—malignant glioma	0.00378	0.00735	CcSEcCtD
Riluzole—Paranoia—Carmustine—malignant glioma	0.00374	0.00728	CcSEcCtD
Riluzole—Thrombosis—Carmustine—malignant glioma	0.0036	0.00701	CcSEcCtD
Riluzole—Interstitial lung disease—Carmustine—malignant glioma	0.0036	0.00701	CcSEcCtD
Riluzole—Lung disorder—Temozolomide—malignant glioma	0.00348	0.00677	CcSEcCtD
Riluzole—Interstitial lung disease—Temozolomide—malignant glioma	0.00348	0.00677	CcSEcCtD
Riluzole—Apathy—Temozolomide—malignant glioma	0.00345	0.00671	CcSEcCtD
Riluzole—Flat affect—Temozolomide—malignant glioma	0.00342	0.00665	CcSEcCtD
Riluzole—Stupor—Carmustine—malignant glioma	0.00342	0.00664	CcSEcCtD
Riluzole—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00327	0.00637	CcSEcCtD
Riluzole—Abscess—Carmustine—malignant glioma	0.00322	0.00627	CcSEcCtD
Riluzole—Petechiae—Temozolomide—malignant glioma	0.003	0.00583	CcSEcCtD
Riluzole—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.003	0.00583	CcSEcCtD
Riluzole—Endocrine disorder—Temozolomide—malignant glioma	0.00297	0.00578	CcSEcCtD
Riluzole—Liver injury—Temozolomide—malignant glioma	0.00293	0.0057	CcSEcCtD
Riluzole—Accidental injury—Carmustine—malignant glioma	0.00288	0.00561	CcSEcCtD
Riluzole—Breast pain—Temozolomide—malignant glioma	0.00282	0.00549	CcSEcCtD
Riluzole—Amenorrhoea—Temozolomide—malignant glioma	0.0028	0.00546	CcSEcCtD
Riluzole—Thinking abnormal—Carmustine—malignant glioma	0.00279	0.00542	CcSEcCtD
Riluzole—Leukocytosis—Carmustine—malignant glioma	0.00271	0.00528	CcSEcCtD
Riluzole—Gait disturbance—Carmustine—malignant glioma	0.00261	0.00508	CcSEcCtD
Riluzole—Coordination abnormal—Carmustine—malignant glioma	0.0026	0.00505	CcSEcCtD
Riluzole—Neck pain—Carmustine—malignant glioma	0.00258	0.00502	CcSEcCtD
Riluzole—Pulmonary embolism—Carmustine—malignant glioma	0.00255	0.00496	CcSEcCtD
Riluzole—Injection site reaction—Carmustine—malignant glioma	0.00254	0.00493	CcSEcCtD
Riluzole—Gait disturbance—Temozolomide—malignant glioma	0.00252	0.00491	CcSEcCtD
Riluzole—Coordination abnormal—Temozolomide—malignant glioma	0.00251	0.00488	CcSEcCtD
Riluzole—Respiratory failure—Temozolomide—malignant glioma	0.00251	0.00488	CcSEcCtD
Riluzole—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00246	0.00479	CcSEcCtD
Riluzole—Pulmonary embolism—Temozolomide—malignant glioma	0.00246	0.00479	CcSEcCtD
Riluzole—Depressed level of consciousness—Carmustine—malignant glioma	0.00246	0.00479	CcSEcCtD
Riluzole—Urinary incontinence—Carmustine—malignant glioma	0.00246	0.00479	CcSEcCtD
Riluzole—Candida infection—Carmustine—malignant glioma	0.00243	0.00474	CcSEcCtD
Riluzole—Depressed level of consciousness—Temozolomide—malignant glioma	0.00238	0.00463	CcSEcCtD
Riluzole—Urinary incontinence—Temozolomide—malignant glioma	0.00238	0.00463	CcSEcCtD
Riluzole—Candida infection—Temozolomide—malignant glioma	0.00235	0.00458	CcSEcCtD
Riluzole—Coma—Carmustine—malignant glioma	0.00233	0.00453	CcSEcCtD
Riluzole—Aplastic anaemia—Temozolomide—malignant glioma	0.00231	0.0045	CcSEcCtD
Riluzole—Neoplasm—Carmustine—malignant glioma	0.00231	0.00448	CcSEcCtD
Riluzole—Neoplasm—Temozolomide—malignant glioma	0.00223	0.00433	CcSEcCtD
Riluzole—Mental disability—Carmustine—malignant glioma	0.00221	0.0043	CcSEcCtD
Riluzole—Sepsis—Carmustine—malignant glioma	0.00221	0.0043	CcSEcCtD
Riluzole—Phlebitis—Carmustine—malignant glioma	0.00215	0.00418	CcSEcCtD
Riluzole—Mental disability—Temozolomide—malignant glioma	0.00214	0.00416	CcSEcCtD
Riluzole—Diabetes mellitus—Carmustine—malignant glioma	0.00213	0.00414	CcSEcCtD
Riluzole—Ear pain—Temozolomide—malignant glioma	0.0021	0.00408	CcSEcCtD
Riluzole—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00206	0.004	CcSEcCtD
Riluzole—Injury—Carmustine—malignant glioma	0.00201	0.00392	CcSEcCtD
Riluzole—Deafness—Temozolomide—malignant glioma	0.002	0.00389	CcSEcCtD
Riluzole—Vascular purpura—Temozolomide—malignant glioma	0.002	0.00389	CcSEcCtD
Riluzole—Amnesia—Carmustine—malignant glioma	0.00197	0.00383	CcSEcCtD
Riluzole—Amnesia—Temozolomide—malignant glioma	0.0019	0.0037	CcSEcCtD
Riluzole—Dermatitis exfoliative—Temozolomide—malignant glioma	0.0019	0.00369	CcSEcCtD
Riluzole—Thirst—Temozolomide—malignant glioma	0.00188	0.00366	CcSEcCtD
Riluzole—Hyponatraemia—Carmustine—malignant glioma	0.00186	0.00362	CcSEcCtD
Riluzole—Purpura—Temozolomide—malignant glioma	0.00186	0.00361	CcSEcCtD
Riluzole—Diplopia—Carmustine—malignant glioma	0.00185	0.0036	CcSEcCtD
Riluzole—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00185	0.0036	CcSEcCtD
Riluzole—Diplopia—Temozolomide—malignant glioma	0.00179	0.00348	CcSEcCtD
Riluzole—Face oedema—Carmustine—malignant glioma	0.00179	0.00348	CcSEcCtD
Riluzole—Affect lability—Temozolomide—malignant glioma	0.00176	0.00342	CcSEcCtD
Riluzole—Ataxia—Carmustine—malignant glioma	0.00174	0.00339	CcSEcCtD
Riluzole—Face oedema—Temozolomide—malignant glioma	0.00173	0.00336	CcSEcCtD
Riluzole—Liver function test abnormal—Carmustine—malignant glioma	0.00171	0.00332	CcSEcCtD
Riluzole—Mood swings—Temozolomide—malignant glioma	0.00169	0.0033	CcSEcCtD
Riluzole—Hypokalaemia—Carmustine—malignant glioma	0.00168	0.00328	CcSEcCtD
Riluzole—Ataxia—Temozolomide—malignant glioma	0.00168	0.00327	CcSEcCtD
Riluzole—Dehydration—Temozolomide—malignant glioma	0.00166	0.00324	CcSEcCtD
Riluzole—Muscular weakness—Carmustine—malignant glioma	0.00163	0.00318	CcSEcCtD
Riluzole—Hypokalaemia—Temozolomide—malignant glioma	0.00163	0.00317	CcSEcCtD
Riluzole—Breast disorder—Temozolomide—malignant glioma	0.00162	0.00314	CcSEcCtD
Riluzole—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00161	0.00313	CcSEcCtD
Riluzole—Dysphagia—Carmustine—malignant glioma	0.0016	0.00311	CcSEcCtD
Riluzole—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00158	0.00307	CcSEcCtD
Riluzole—Muscular weakness—Temozolomide—malignant glioma	0.00158	0.00307	CcSEcCtD
Riluzole—Abdominal distension—Temozolomide—malignant glioma	0.00156	0.00303	CcSEcCtD
Riluzole—Dysphagia—Temozolomide—malignant glioma	0.00155	0.00301	CcSEcCtD
Riluzole—Pancytopenia—Carmustine—malignant glioma	0.00152	0.00296	CcSEcCtD
Riluzole—Neutropenia—Carmustine—malignant glioma	0.0015	0.00291	CcSEcCtD
Riluzole—Bronchitis—Temozolomide—malignant glioma	0.00149	0.00289	CcSEcCtD
Riluzole—Pancytopenia—Temozolomide—malignant glioma	0.00147	0.00286	CcSEcCtD
Riluzole—Dysuria—Temozolomide—malignant glioma	0.00145	0.00281	CcSEcCtD
Riluzole—Neutropenia—Temozolomide—malignant glioma	0.00145	0.00281	CcSEcCtD
Riluzole—Pneumonia—Carmustine—malignant glioma	0.00143	0.00279	CcSEcCtD
Riluzole—Pollakiuria—Temozolomide—malignant glioma	0.00143	0.00278	CcSEcCtD
Riluzole—Erectile dysfunction—Temozolomide—malignant glioma	0.00142	0.00277	CcSEcCtD
Riluzole—Depression—Carmustine—malignant glioma	0.00142	0.00277	CcSEcCtD
Riluzole—Photosensitivity reaction—Temozolomide—malignant glioma	0.00141	0.00274	CcSEcCtD
Riluzole—Weight increased—Temozolomide—malignant glioma	0.00141	0.00274	CcSEcCtD
Riluzole—Weight decreased—Temozolomide—malignant glioma	0.0014	0.00272	CcSEcCtD
Riluzole—Neuropathy peripheral—Carmustine—malignant glioma	0.0014	0.00272	CcSEcCtD
Riluzole—Stomatitis—Carmustine—malignant glioma	0.00139	0.0027	CcSEcCtD
Riluzole—Urinary tract infection—Carmustine—malignant glioma	0.00139	0.0027	CcSEcCtD
Riluzole—Pneumonia—Temozolomide—malignant glioma	0.00139	0.0027	CcSEcCtD
Riluzole—Infestation NOS—Temozolomide—malignant glioma	0.00138	0.00268	CcSEcCtD
Riluzole—Infestation—Temozolomide—malignant glioma	0.00138	0.00268	CcSEcCtD
Riluzole—Depression—Temozolomide—malignant glioma	0.00137	0.00267	CcSEcCtD
Riluzole—Neuropathy peripheral—Temozolomide—malignant glioma	0.00135	0.00263	CcSEcCtD
Riluzole—Stomatitis—Temozolomide—malignant glioma	0.00134	0.00261	CcSEcCtD
Riluzole—Urinary tract infection—Temozolomide—malignant glioma	0.00134	0.00261	CcSEcCtD
Riluzole—Hepatobiliary disease—Temozolomide—malignant glioma	0.0013	0.00254	CcSEcCtD
Riluzole—Sinusitis—Temozolomide—malignant glioma	0.00129	0.00252	CcSEcCtD
Riluzole—Haemoglobin—Carmustine—malignant glioma	0.00129	0.0025	CcSEcCtD
Riluzole—Haemorrhage—Carmustine—malignant glioma	0.00128	0.00249	CcSEcCtD
Riluzole—Hallucination—Carmustine—malignant glioma	0.00127	0.00248	CcSEcCtD
Riluzole—Hypoaesthesia—Carmustine—malignant glioma	0.00127	0.00248	CcSEcCtD
Riluzole—Oedema peripheral—Carmustine—malignant glioma	0.00126	0.00245	CcSEcCtD
Riluzole—Connective tissue disorder—Carmustine—malignant glioma	0.00126	0.00245	CcSEcCtD
Riluzole—Haemoglobin—Temozolomide—malignant glioma	0.00124	0.00242	CcSEcCtD
Riluzole—Haemorrhage—Temozolomide—malignant glioma	0.00124	0.00241	CcSEcCtD
Riluzole—Hepatitis—Temozolomide—malignant glioma	0.00124	0.00241	CcSEcCtD
Riluzole—Hypoaesthesia—Temozolomide—malignant glioma	0.00123	0.0024	CcSEcCtD
Riluzole—Hallucination—Temozolomide—malignant glioma	0.00123	0.0024	CcSEcCtD
Riluzole—Pharyngitis—Temozolomide—malignant glioma	0.00123	0.00239	CcSEcCtD
Riluzole—Urinary tract disorder—Temozolomide—malignant glioma	0.00122	0.00238	CcSEcCtD
Riluzole—Oedema peripheral—Temozolomide—malignant glioma	0.00122	0.00237	CcSEcCtD
Riluzole—Connective tissue disorder—Temozolomide—malignant glioma	0.00122	0.00237	CcSEcCtD
Riluzole—Urethral disorder—Temozolomide—malignant glioma	0.00121	0.00236	CcSEcCtD
Riluzole—Eye disorder—Carmustine—malignant glioma	0.0012	0.00233	CcSEcCtD
Riluzole—Erythema multiforme—Temozolomide—malignant glioma	0.00117	0.00228	CcSEcCtD
Riluzole—Eye disorder—Temozolomide—malignant glioma	0.00116	0.00225	CcSEcCtD
Riluzole—Cardiac disorder—Temozolomide—malignant glioma	0.00115	0.00223	CcSEcCtD
Riluzole—Arrhythmia—Carmustine—malignant glioma	0.00114	0.00223	CcSEcCtD
Riluzole—Alopecia—Carmustine—malignant glioma	0.00113	0.0022	CcSEcCtD
Riluzole—Angiopathy—Temozolomide—malignant glioma	0.00112	0.00218	CcSEcCtD
Riluzole—Mental disorder—Carmustine—malignant glioma	0.00112	0.00218	CcSEcCtD
Riluzole—Immune system disorder—Temozolomide—malignant glioma	0.00112	0.00217	CcSEcCtD
Riluzole—Mediastinal disorder—Temozolomide—malignant glioma	0.00112	0.00217	CcSEcCtD
Riluzole—Malnutrition—Carmustine—malignant glioma	0.00111	0.00217	CcSEcCtD
Riluzole—Chills—Temozolomide—malignant glioma	0.00111	0.00216	CcSEcCtD
Riluzole—Alopecia—Temozolomide—malignant glioma	0.00109	0.00213	CcSEcCtD
Riluzole—Mental disorder—Temozolomide—malignant glioma	0.00108	0.00211	CcSEcCtD
Riluzole—Back pain—Carmustine—malignant glioma	0.00108	0.0021	CcSEcCtD
Riluzole—Malnutrition—Temozolomide—malignant glioma	0.00108	0.0021	CcSEcCtD
Riluzole—Dysgeusia—Temozolomide—malignant glioma	0.00105	0.00205	CcSEcCtD
Riluzole—Tremor—Carmustine—malignant glioma	0.00104	0.00203	CcSEcCtD
Riluzole—Back pain—Temozolomide—malignant glioma	0.00104	0.00203	CcSEcCtD
Riluzole—Anaemia—Carmustine—malignant glioma	0.00103	0.002	CcSEcCtD
Riluzole—Agitation—Carmustine—malignant glioma	0.00102	0.00199	CcSEcCtD
Riluzole—Tremor—Temozolomide—malignant glioma	0.00101	0.00196	CcSEcCtD
Riluzole—Ill-defined disorder—Temozolomide—malignant glioma	0.001	0.00194	CcSEcCtD
Riluzole—Leukopenia—Carmustine—malignant glioma	0.000998	0.00194	CcSEcCtD
Riluzole—Anaemia—Temozolomide—malignant glioma	0.000996	0.00194	CcSEcCtD
Riluzole—Agitation—Temozolomide—malignant glioma	0.00099	0.00193	CcSEcCtD
Riluzole—Angioedema—Temozolomide—malignant glioma	0.000984	0.00191	CcSEcCtD
Riluzole—Malaise—Temozolomide—malignant glioma	0.000971	0.00189	CcSEcCtD
Riluzole—Vertigo—Temozolomide—malignant glioma	0.000968	0.00188	CcSEcCtD
Riluzole—Convulsion—Carmustine—malignant glioma	0.000966	0.00188	CcSEcCtD
Riluzole—Leukopenia—Temozolomide—malignant glioma	0.000964	0.00188	CcSEcCtD
Riluzole—Hypertension—Carmustine—malignant glioma	0.000962	0.00187	CcSEcCtD
Riluzole—Palpitations—Temozolomide—malignant glioma	0.000952	0.00185	CcSEcCtD
Riluzole—Chest pain—Carmustine—malignant glioma	0.000949	0.00185	CcSEcCtD
Riluzole—Myalgia—Carmustine—malignant glioma	0.000949	0.00185	CcSEcCtD
Riluzole—Anxiety—Carmustine—malignant glioma	0.000946	0.00184	CcSEcCtD
Riluzole—Cough—Temozolomide—malignant glioma	0.00094	0.00183	CcSEcCtD
Riluzole—Convulsion—Temozolomide—malignant glioma	0.000933	0.00182	CcSEcCtD
Riluzole—Hypertension—Temozolomide—malignant glioma	0.00093	0.00181	CcSEcCtD
Riluzole—Confusional state—Carmustine—malignant glioma	0.000917	0.00178	CcSEcCtD
Riluzole—Myalgia—Temozolomide—malignant glioma	0.000917	0.00178	CcSEcCtD
Riluzole—Arthralgia—Temozolomide—malignant glioma	0.000917	0.00178	CcSEcCtD
Riluzole—Anxiety—Temozolomide—malignant glioma	0.000914	0.00178	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000911	0.00177	CcSEcCtD
Riluzole—Oedema—Carmustine—malignant glioma	0.00091	0.00177	CcSEcCtD
Riluzole—Discomfort—Temozolomide—malignant glioma	0.000906	0.00176	CcSEcCtD
Riluzole—Infection—Carmustine—malignant glioma	0.000904	0.00176	CcSEcCtD
Riluzole—Dry mouth—Temozolomide—malignant glioma	0.000897	0.00174	CcSEcCtD
Riluzole—Thrombocytopenia—Carmustine—malignant glioma	0.000891	0.00173	CcSEcCtD
Riluzole—Tachycardia—Carmustine—malignant glioma	0.000888	0.00173	CcSEcCtD
Riluzole—Confusional state—Temozolomide—malignant glioma	0.000887	0.00172	CcSEcCtD
Riluzole—Anaphylactic shock—Temozolomide—malignant glioma	0.000879	0.00171	CcSEcCtD
Riluzole—Oedema—Temozolomide—malignant glioma	0.000879	0.00171	CcSEcCtD
Riluzole—Infection—Temozolomide—malignant glioma	0.000873	0.0017	CcSEcCtD
Riluzole—Anorexia—Carmustine—malignant glioma	0.000867	0.00169	CcSEcCtD
Riluzole—Nervous system disorder—Temozolomide—malignant glioma	0.000862	0.00168	CcSEcCtD
Riluzole—Thrombocytopenia—Temozolomide—malignant glioma	0.000861	0.00167	CcSEcCtD
Riluzole—Skin disorder—Temozolomide—malignant glioma	0.000854	0.00166	CcSEcCtD
Riluzole—Hypotension—Carmustine—malignant glioma	0.00085	0.00165	CcSEcCtD
Riluzole—Hyperhidrosis—Temozolomide—malignant glioma	0.00085	0.00165	CcSEcCtD
Riluzole—Anorexia—Temozolomide—malignant glioma	0.000838	0.00163	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000829	0.00161	CcSEcCtD
Riluzole—Insomnia—Carmustine—malignant glioma	0.000823	0.0016	CcSEcCtD
Riluzole—Paraesthesia—Carmustine—malignant glioma	0.000817	0.00159	CcSEcCtD
Riluzole—Dyspnoea—Carmustine—malignant glioma	0.000811	0.00158	CcSEcCtD
Riluzole—Somnolence—Carmustine—malignant glioma	0.000809	0.00157	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000801	0.00156	CcSEcCtD
Riluzole—Insomnia—Temozolomide—malignant glioma	0.000795	0.00155	CcSEcCtD
Riluzole—Decreased appetite—Carmustine—malignant glioma	0.000791	0.00154	CcSEcCtD
Riluzole—Paraesthesia—Temozolomide—malignant glioma	0.000789	0.00154	CcSEcCtD
Riluzole—Gastrointestinal disorder—Carmustine—malignant glioma	0.000785	0.00153	CcSEcCtD
Riluzole—Dyspnoea—Temozolomide—malignant glioma	0.000784	0.00152	CcSEcCtD
Riluzole—Somnolence—Temozolomide—malignant glioma	0.000782	0.00152	CcSEcCtD
Riluzole—Pain—Carmustine—malignant glioma	0.000778	0.00151	CcSEcCtD
Riluzole—Constipation—Carmustine—malignant glioma	0.000778	0.00151	CcSEcCtD
Riluzole—Dyspepsia—Temozolomide—malignant glioma	0.000774	0.00151	CcSEcCtD
Riluzole—Decreased appetite—Temozolomide—malignant glioma	0.000764	0.00149	CcSEcCtD
Riluzole—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000759	0.00148	CcSEcCtD
Riluzole—Fatigue—Temozolomide—malignant glioma	0.000758	0.00147	CcSEcCtD
Riluzole—Pain—Temozolomide—malignant glioma	0.000752	0.00146	CcSEcCtD
Riluzole—Constipation—Temozolomide—malignant glioma	0.000752	0.00146	CcSEcCtD
Riluzole—Feeling abnormal—Carmustine—malignant glioma	0.00075	0.00146	CcSEcCtD
Riluzole—Gastrointestinal pain—Carmustine—malignant glioma	0.000744	0.00145	CcSEcCtD
Riluzole—Feeling abnormal—Temozolomide—malignant glioma	0.000725	0.00141	CcSEcCtD
Riluzole—Abdominal pain—Carmustine—malignant glioma	0.000719	0.0014	CcSEcCtD
Riluzole—Body temperature increased—Carmustine—malignant glioma	0.000719	0.0014	CcSEcCtD
Riluzole—Gastrointestinal pain—Temozolomide—malignant glioma	0.000719	0.0014	CcSEcCtD
Riluzole—Urticaria—Temozolomide—malignant glioma	0.000698	0.00136	CcSEcCtD
Riluzole—Abdominal pain—Temozolomide—malignant glioma	0.000695	0.00135	CcSEcCtD
Riluzole—Body temperature increased—Temozolomide—malignant glioma	0.000695	0.00135	CcSEcCtD
Riluzole—Hypersensitivity—Carmustine—malignant glioma	0.00067	0.0013	CcSEcCtD
Riluzole—Asthenia—Carmustine—malignant glioma	0.000653	0.00127	CcSEcCtD
Riluzole—Hypersensitivity—Temozolomide—malignant glioma	0.000648	0.00126	CcSEcCtD
Riluzole—Asthenia—Temozolomide—malignant glioma	0.000631	0.00123	CcSEcCtD
Riluzole—Diarrhoea—Carmustine—malignant glioma	0.000623	0.00121	CcSEcCtD
Riluzole—Pruritus—Temozolomide—malignant glioma	0.000622	0.00121	CcSEcCtD
Riluzole—Dizziness—Carmustine—malignant glioma	0.000602	0.00117	CcSEcCtD
Riluzole—Diarrhoea—Temozolomide—malignant glioma	0.000602	0.00117	CcSEcCtD
Riluzole—Dizziness—Temozolomide—malignant glioma	0.000581	0.00113	CcSEcCtD
Riluzole—Vomiting—Carmustine—malignant glioma	0.000578	0.00113	CcSEcCtD
Riluzole—Rash—Carmustine—malignant glioma	0.000574	0.00112	CcSEcCtD
Riluzole—Dermatitis—Carmustine—malignant glioma	0.000573	0.00111	CcSEcCtD
Riluzole—Headache—Carmustine—malignant glioma	0.00057	0.00111	CcSEcCtD
Riluzole—CYP1A2—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000564	0.00352	CbGpPWpGaD
Riluzole—Vomiting—Temozolomide—malignant glioma	0.000559	0.00109	CcSEcCtD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—TERT—malignant glioma	0.000557	0.00347	CbGpPWpGaD
Riluzole—Rash—Temozolomide—malignant glioma	0.000554	0.00108	CcSEcCtD
Riluzole—Dermatitis—Temozolomide—malignant glioma	0.000554	0.00108	CcSEcCtD
Riluzole—Headache—Temozolomide—malignant glioma	0.000551	0.00107	CcSEcCtD
Riluzole—CYP1A1—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000551	0.00343	CbGpPWpGaD
Riluzole—Nausea—Carmustine—malignant glioma	0.00054	0.00105	CcSEcCtD
Riluzole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000534	0.00333	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	0.000533	0.00332	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—HES1—malignant glioma	0.000523	0.00326	CbGpPWpGaD
Riluzole—Nausea—Temozolomide—malignant glioma	0.000522	0.00102	CcSEcCtD
Riluzole—CYP1A2—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000501	0.00312	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—H3F3A—malignant glioma	0.000498	0.00311	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malignant glioma	0.000498	0.0031	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—GDNF—malignant glioma	0.000492	0.00307	CbGpPWpGaD
Riluzole—ABCG2—HIF-2-alpha transcription factor network—VEGFA—malignant glioma	0.000477	0.00297	CbGpPWpGaD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—KRAS—malignant glioma	0.000476	0.00297	CbGpPWpGaD
Riluzole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000463	0.00289	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—CYP2B6—malignant glioma	0.000445	0.00277	CbGpPWpGaD
Riluzole—CYP1A2—Estrogen Receptor Pathway—STAT3—malignant glioma	0.00044	0.00274	CbGpPWpGaD
Riluzole—CYP1A1—Metapathway biotransformation—CYP2B6—malignant glioma	0.000439	0.00274	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000438	0.00273	CbGpPWpGaD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—PIK3CA—malignant glioma	0.000438	0.00273	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000436	0.00272	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—KNG1—malignant glioma	0.000411	0.00256	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—IFNA2—malignant glioma	0.000402	0.00251	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.0004	0.00249	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000396	0.00247	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—CYP2C18—malignant glioma	0.000386	0.00241	CbGpPWpGaD
Riluzole—CYP1A2—Tryptophan metabolism—CAT—malignant glioma	0.000386	0.0024	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—SOD1—malignant glioma	0.000381	0.00238	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000381	0.00237	CbGpPWpGaD
Riluzole—CYP1A1—Metapathway biotransformation—CYP2C18—malignant glioma	0.000381	0.00237	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—SOX2—malignant glioma	0.000373	0.00232	CbGpPWpGaD
Riluzole—ABCG2—Fluoropyrimidine Activity—TP53—malignant glioma	0.000369	0.0023	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—malignant glioma	0.000366	0.00228	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000362	0.00226	CbGpPWpGaD
Riluzole—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000351	0.00219	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—PTK2—malignant glioma	0.00035	0.00218	CbGpPWpGaD
Riluzole—CYP1A2—Phase II conjugation—GSTT1—malignant glioma	0.00034	0.00212	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	0.000336	0.00209	CbGpPWpGaD
Riluzole—CYP1A1—Tryptophan metabolism—MDM2—malignant glioma	0.000334	0.00208	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.000333	0.00207	CbGpPWpGaD
Riluzole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000332	0.00207	CbGpPWpGaD
Riluzole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	0.000328	0.00204	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—RTEL1—malignant glioma	0.000323	0.00201	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	0.000322	0.00201	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000317	0.00197	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—GSTT1—malignant glioma	0.000312	0.00195	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—APOD—malignant glioma	0.000308	0.00192	CbGpPWpGaD
Riluzole—SCN5A—L1CAM interactions—EGFR—malignant glioma	0.000306	0.00191	CbGpPWpGaD
Riluzole—CYP1A1—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000301	0.00188	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	0.0003	0.00187	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	0.000298	0.00186	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—PTK2—malignant glioma	0.000296	0.00185	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—PDGFB—malignant glioma	0.000294	0.00183	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—PTGS1—malignant glioma	0.000292	0.00182	CbGpPWpGaD
Riluzole—CYP1A1—PPARA activates gene expression—NCOR1—malignant glioma	0.000284	0.00177	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000284	0.00177	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—CYP2B6—malignant glioma	0.000284	0.00177	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000281	0.00175	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—CYP2B6—malignant glioma	0.00028	0.00174	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—CAV1—malignant glioma	0.000279	0.00174	CbGpPWpGaD
Riluzole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—malignant glioma	0.000278	0.00173	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000273	0.0017	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000272	0.00169	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—FN1—malignant glioma	0.000265	0.00165	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—F2—malignant glioma	0.000265	0.00165	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—PIK3CG—malignant glioma	0.000254	0.00158	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.000254	0.00158	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—EGF—malignant glioma	0.000251	0.00157	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—PTPN11—malignant glioma	0.00025	0.00156	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—FGFR1—malignant glioma	0.000248	0.00154	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—CYP2C18—malignant glioma	0.000246	0.00153	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—CYP2C18—malignant glioma	0.000243	0.00151	CbGpPWpGaD
Riluzole—CYP1A2—Phase II conjugation—GSTP1—malignant glioma	0.000236	0.00147	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—KDR—malignant glioma	0.000233	0.00145	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—malignant glioma	0.000233	0.00145	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—AKT2—malignant glioma	0.000232	0.00145	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000231	0.00144	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—MET—malignant glioma	0.000228	0.00142	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	0.000228	0.00142	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	0.000228	0.00142	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—PIK3CD—malignant glioma	0.000223	0.00139	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—RTEL1—malignant glioma	0.000219	0.00136	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	0.000217	0.00135	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—malignant glioma	0.000217	0.00135	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—GSTP1—malignant glioma	0.000216	0.00135	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	0.000216	0.00134	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	0.000214	0.00133	CbGpPWpGaD
Riluzole—CYP1A1—Metapathway biotransformation—GSTP1—malignant glioma	0.000213	0.00133	CbGpPWpGaD
Riluzole—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	0.000213	0.00133	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.000212	0.00132	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—PTK2—malignant glioma	0.000212	0.00132	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—PTPN11—malignant glioma	0.000211	0.00132	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—HES1—malignant glioma	0.000208	0.0013	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—NCOR1—malignant glioma	0.000207	0.00129	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	0.000205	0.00128	CbGpPWpGaD
Riluzole—CYP1A1—PPARA activates gene expression—PPARG—malignant glioma	0.000204	0.00127	CbGpPWpGaD
Riluzole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—malignant glioma	0.000199	0.00124	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—RAF1—malignant glioma	0.000199	0.00124	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—GSTT1—malignant glioma	0.000199	0.00124	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000198	0.00123	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—PIK3CB—malignant glioma	0.000195	0.00121	CbGpPWpGaD
Riluzole—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000192	0.0012	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—malignant glioma	0.000192	0.0012	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	0.000191	0.00119	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—MMP2—malignant glioma	0.000191	0.00119	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	0.00019	0.00119	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—PTGS1—malignant glioma	0.000186	0.00116	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—COX8A—malignant glioma	0.000186	0.00116	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000179	0.00112	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—IL2—malignant glioma	0.000179	0.00111	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—FGFR1—malignant glioma	0.000177	0.0011	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000173	0.00108	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—RAF1—malignant glioma	0.000169	0.00105	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—ERBB2—malignant glioma	0.000167	0.00104	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—KDR—malignant glioma	0.000167	0.00104	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MET—malignant glioma	0.000163	0.00102	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.000162	0.00101	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ASMT—malignant glioma	0.000158	0.000984	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000158	0.000984	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—NOTCH1—malignant glioma	0.000157	0.000978	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000156	0.000975	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—VEGFA—malignant glioma	0.000152	0.000947	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000151	0.000943	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—PTPN11—malignant glioma	0.000151	0.00094	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	0.000149	0.000927	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—BCAN—malignant glioma	0.000148	0.000925	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—PPARG—malignant glioma	0.000148	0.000923	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	0.000146	0.000907	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	0.000146	0.000907	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000145	0.000903	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—MMP9—malignant glioma	0.000143	0.000893	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—AKT2—malignant glioma	0.00014	0.000875	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—RTEL1—malignant glioma	0.000139	0.00087	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	0.000139	0.000864	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	0.000139	0.000864	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—GSTP1—malignant glioma	0.000138	0.00086	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000138	0.00086	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	0.000137	0.000857	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—malignant glioma	0.000137	0.000856	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	0.000136	0.000848	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MMP2—malignant glioma	0.000136	0.000847	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—KRAS—malignant glioma	0.000129	0.000805	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—FGF2—malignant glioma	0.000129	0.000805	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—VEGFA—malignant glioma	0.000129	0.000802	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—COX8A—malignant glioma	0.000126	0.000783	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—RAF1—malignant glioma	0.00012	0.000751	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—IDH2—malignant glioma	0.00012	0.000746	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—ERBB2—malignant glioma	0.000119	0.000743	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—PIK3CA—malignant glioma	0.000119	0.00074	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—EGFR—malignant glioma	0.000116	0.000721	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—TP53—malignant glioma	0.000115	0.000715	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP2B6—malignant glioma	0.000112	0.000701	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000112	0.0007	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—KRAS—malignant glioma	0.000109	0.000681	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ASMT—malignant glioma	0.000107	0.000666	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000104	0.000651	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—IDH1—malignant glioma	0.000103	0.000641	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MMP9—malignant glioma	0.000102	0.000637	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—BCAN—malignant glioma	0.0001	0.000626	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	9.97e-05	0.000621	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SPHK1—malignant glioma	9.95e-05	0.00062	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP2C18—malignant glioma	9.75e-05	0.000608	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—AKT1—malignant glioma	9.69e-05	0.000604	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	9.65e-05	0.000601	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—VEGFA—malignant glioma	9.17e-05	0.000572	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—STAT3—malignant glioma	9.08e-05	0.000566	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—EGFR—malignant glioma	8.26e-05	0.000515	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—IDH2—malignant glioma	8.1e-05	0.000505	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—COX8A—malignant glioma	8.01e-05	0.000499	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTT1—malignant glioma	7.89e-05	0.000492	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—TNF—malignant glioma	7.86e-05	0.00049	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—KRAS—malignant glioma	7.8e-05	0.000486	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	7.63e-05	0.000476	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP2B6—malignant glioma	7.61e-05	0.000475	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PTGS1—malignant glioma	7.39e-05	0.000461	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	7.16e-05	0.000446	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—IDH1—malignant glioma	6.96e-05	0.000434	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—BCHE—malignant glioma	6.87e-05	0.000428	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ASMT—malignant glioma	6.81e-05	0.000425	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SLC5A5—malignant glioma	6.79e-05	0.000423	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SPHK1—malignant glioma	6.74e-05	0.00042	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	6.66e-05	0.000415	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP2C18—malignant glioma	6.6e-05	0.000411	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—BCAN—malignant glioma	6.4e-05	0.000399	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—RAF1—malignant glioma	6.25e-05	0.00039	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.22e-05	0.000388	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—AKT1—malignant glioma	5.85e-05	0.000365	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.67e-05	0.000353	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.47e-05	0.000341	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTP1—malignant glioma	5.47e-05	0.000341	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTT1—malignant glioma	5.34e-05	0.000333	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CAT—malignant glioma	5.32e-05	0.000332	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—IDH2—malignant glioma	5.16e-05	0.000322	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NCOR1—malignant glioma	5.02e-05	0.000313	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PTGS1—malignant glioma	5e-05	0.000312	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.98e-05	0.000311	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.87e-05	0.000303	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP2B6—malignant glioma	4.85e-05	0.000303	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—BCHE—malignant glioma	4.65e-05	0.00029	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SLC5A5—malignant glioma	4.59e-05	0.000286	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—IDH1—malignant glioma	4.44e-05	0.000277	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.34e-05	0.000271	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.3e-05	0.000268	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SPHK1—malignant glioma	4.3e-05	0.000268	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP2C18—malignant glioma	4.21e-05	0.000262	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CAV1—malignant glioma	4.09e-05	0.000255	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.97e-05	0.000247	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.75e-05	0.000234	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CG—malignant glioma	3.73e-05	0.000233	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTP1—malignant glioma	3.7e-05	0.000231	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.61e-05	0.000225	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CAT—malignant glioma	3.6e-05	0.000224	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PPARG—malignant glioma	3.6e-05	0.000224	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.49e-05	0.000217	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTT1—malignant glioma	3.4e-05	0.000212	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NCOR1—malignant glioma	3.4e-05	0.000212	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CD—malignant glioma	3.28e-05	0.000204	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PTGS1—malignant glioma	3.19e-05	0.000199	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.18e-05	0.000198	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—BCHE—malignant glioma	2.97e-05	0.000185	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SLC5A5—malignant glioma	2.93e-05	0.000183	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CB—malignant glioma	2.86e-05	0.000178	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PTGS2—malignant glioma	2.83e-05	0.000177	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CAV1—malignant glioma	2.77e-05	0.000173	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.77e-05	0.000173	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.74e-05	0.000171	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.65e-05	0.000165	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CG—malignant glioma	2.52e-05	0.000157	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PTEN—malignant glioma	2.47e-05	0.000154	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PPARG—malignant glioma	2.44e-05	0.000152	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.39e-05	0.000149	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTP1—malignant glioma	2.36e-05	0.000147	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CAT—malignant glioma	2.3e-05	0.000143	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CD—malignant glioma	2.22e-05	0.000138	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NCOR1—malignant glioma	2.17e-05	0.000135	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CB—malignant glioma	1.93e-05	0.000121	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PTGS2—malignant glioma	1.92e-05	0.000119	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CAV1—malignant glioma	1.77e-05	0.00011	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CA—malignant glioma	1.74e-05	0.000109	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.69e-05	0.000105	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PTEN—malignant glioma	1.67e-05	0.000104	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.61e-05	0.0001	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PPARG—malignant glioma	1.55e-05	9.69e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—AKT1—malignant glioma	1.42e-05	8.87e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.42e-05	8.82e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.23e-05	7.69e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PTGS2—malignant glioma	1.22e-05	7.62e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CA—malignant glioma	1.18e-05	7.35e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PTEN—malignant glioma	1.07e-05	6.64e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—AKT1—malignant glioma	9.63e-06	6.01e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CA—malignant glioma	7.52e-06	4.69e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—AKT1—malignant glioma	6.14e-06	3.83e-05	CbGpPWpGaD
